SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

NCT00095953 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: ispinesib

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]